Recent Company News

• 11:32 AM ET Aug 22, 2025
  

  StreetAccount Activist Summary: Week of 18-Aug

• 07:22 PM ET Aug 19, 2025
  

  Adaptimmune Therapeutics holder New Enterprise Associates discloses sale of 17.1M-ADS (102.5M-share) holding - 13D/A ($0.06, 0.00)

• 10:12 AM ET Aug 13, 2025
  

  Adaptimmune Nicks Higher on Q2 Results

• 07:34 AM ET Aug 13, 2025
  

  Adaptimmune Therapeutics reports Q2 EPS ($0.02) vs FactSet ($0.04) [5 est, ($0.13)-0.00] ($0.08, 0.00)

• 07:31 AM ET Aug 13, 2025
  

  Adaptimmune Reports Q2 Financial Results and Provides Business Update

• 09:53 PM ET Jul 29, 2025
  

  Adaptimmune Therapeutics downgraded to neutral from buy at Guggenheim Securities ($0.10, 0.00)

• 05:00 PM ET Jul 29, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:18 AM ET Jul 29, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 09:02 AM ET Jul 29, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:23 AM ET Jul 29, 2025
  

  StreetAccount Summary - US Pre-market trading